Moreover, the pathophysiology of anti‐TNF in the emergence of SLE remains unclear, and several theories have attempted to explain the prevalence of lupus or lupus‐like symptoms in patients receiving anti‐TNF medication. This evidence concerns the gene TNF and systemic lupus erythematosus.